These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 15459967

  • 1. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E.
    J Gene Med; 2004 Nov; 6(11):1216-27. PubMed ID: 15459967
    [Abstract] [Full Text] [Related]

  • 2. Targeting the cytotoxicity of fusogenic membrane glycoproteins in gliomas through protease-substrate interaction.
    Johnson KJ, Peng KW, Allen C, Russell SJ, Galanis E.
    Gene Ther; 2003 May; 10(9):725-32. PubMed ID: 12704411
    [Abstract] [Full Text] [Related]

  • 3. Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein.
    Kirkham LA, Bateman AR, Melcher AA, Vile RG, Fielding AK.
    J Gene Med; 2002 May; 4(6):592-600. PubMed ID: 12439851
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy for malignant glioma using Sindbis vectors expressing a fusogenic membrane glycoprotein.
    Zhang J, Frolov I, Russell SJ.
    J Gene Med; 2004 Oct; 6(10):1082-91. PubMed ID: 15368589
    [Abstract] [Full Text] [Related]

  • 5. Use of viral fusogenic membrane glycoproteins as novel therapeutic transgenes in gliomas.
    Galanis E, Bateman A, Johnson K, Diaz RM, James CD, Vile R, Russell SJ.
    Hum Gene Ther; 2001 May 01; 12(7):811-21. PubMed ID: 11339897
    [Abstract] [Full Text] [Related]

  • 6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase.
    Nanda D, Vogels R, Havenga M, Avezaat CJ, Bout A, Smitt PS.
    Cancer Res; 2001 Dec 15; 61(24):8743-50. PubMed ID: 11751394
    [Abstract] [Full Text] [Related]

  • 7. Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.
    Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ.
    Cancer Res; 2000 Nov 15; 60(22):6396-402. PubMed ID: 11103804
    [Abstract] [Full Text] [Related]

  • 8. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK, Allen C, Peng KW, Giannini C, Greiner S, TenEyck CJ, Mishra PK, Macura SI, Russell SJ, Galanis EC.
    Cancer Res; 2003 May 15; 63(10):2462-9. PubMed ID: 12750267
    [Abstract] [Full Text] [Related]

  • 9. Tissue inhibitor of metalloproteinase-3 expression from an oncolytic adenovirus inhibits matrix metalloproteinase activity in vivo without affecting antitumor efficacy in malignant glioma.
    Lamfers ML, Gianni D, Tung CH, Idema S, Schagen FH, Carette JE, Quax PH, Van Beusechem VW, Vandertop WP, Dirven CM, Chiocca EA, Gerritsen WR.
    Cancer Res; 2005 Oct 15; 65(20):9398-405. PubMed ID: 16230403
    [Abstract] [Full Text] [Related]

  • 10. Fusogenic membrane glycoproteins induce syncytia formation and death in vitro and in vivo: a potential therapy agent for lung cancer.
    Lin EH, Salon C, Brambilla E, Lavillette D, Szecsi J, Cosset FL, Coll JL.
    Cancer Gene Ther; 2010 Apr 15; 17(4):256-65. PubMed ID: 19893593
    [Abstract] [Full Text] [Related]

  • 11. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
    Kaliberov S, Stackhouse MA, Kaliberova L, Zhou T, Buchsbaum DJ.
    Gene Ther; 2004 Apr 15; 11(8):658-67. PubMed ID: 14973547
    [Abstract] [Full Text] [Related]

  • 12. Intratumoral expression of a fusogenic membrane glycoprotein enhances the efficacy of replicating adenovirus therapy.
    Ahmed A, Jevremovic D, Suzuki K, Kottke T, Thompson J, Emery S, Harrington K, Bateman A, Vile R.
    Gene Ther; 2003 Sep 15; 10(19):1663-71. PubMed ID: 12923565
    [Abstract] [Full Text] [Related]

  • 13. GALV expression enhances the therapeutic efficacy of an oncolytic adenovirus by inducing cell fusion and enhancing virus distribution.
    Guedan S, Grases D, Rojas JJ, Gros A, Vilardell F, Vile R, Mercade E, Cascallo M, Alemany R.
    Gene Ther; 2012 Nov 15; 19(11):1048-57. PubMed ID: 22113313
    [Abstract] [Full Text] [Related]

  • 14. A lentiviral vector expressing a fusogenic glycoprotein for cancer gene therapy.
    Diaz RM, Bateman A, Emiliusen L, Fielding A, Trono D, Russell SJ, Vile RG.
    Gene Ther; 2000 Oct 15; 7(19):1656-63. PubMed ID: 11083474
    [Abstract] [Full Text] [Related]

  • 15. A hyperfusogenic gibbon ape leukemia envelope glycoprotein: targeting of a cytotoxic gene by ligand display.
    Fielding AK, Chapel-Fernandes S, Chadwick MP, Bullough FJ, Cosset FL, Russell SJ.
    Hum Gene Ther; 2000 Apr 10; 11(6):817-26. PubMed ID: 10779159
    [Abstract] [Full Text] [Related]

  • 16. Combination of a fusogenic glycoprotein, prodrug activation, and oncolytic herpes simplex virus for enhanced local tumor control.
    Simpson GR, Han Z, Liu B, Wang Y, Campbell G, Coffin RS.
    Cancer Res; 2006 May 01; 66(9):4835-42. PubMed ID: 16651439
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of NF-kappaB in fusogenic membrane glycoprotein causing HL-60 cell death: implications for acute myeloid leukemia.
    Tan L, Jia H, Liu R, Wu J, Han H, Zuo Y, Yang S, Huang W.
    Cancer Lett; 2009 Jan 08; 273(1):114-21. PubMed ID: 18783878
    [Abstract] [Full Text] [Related]

  • 18. [The construction of recombinant type I herpes simplex virus carrying GALV.fus gene and its antitumor effect in nude mice].
    Zhu M, Yang JR, Jiang YQ, Chen SF, Fu XP, Tian ZD.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar 08; 42(2):152-6. PubMed ID: 21500543
    [Abstract] [Full Text] [Related]

  • 19. Cancer gene therapy using a novel secretable trimeric TRAIL.
    Kim CY, Jeong M, Mushiake H, Kim BM, Kim WB, Ko JP, Kim MH, Kim M, Kim TH, Robbins PD, Billiar TR, Seol DW.
    Gene Ther; 2006 Feb 08; 13(4):330-8. PubMed ID: 16195699
    [Abstract] [Full Text] [Related]

  • 20. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D, Bayer W, Wildner O.
    Int J Mol Med; 2007 Nov 08; 20(5):673-81. PubMed ID: 17912460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.